Holen Sie sich die Stockscreener-App
0.00
100.00%
-11.13
Schlusskurs vom Vortag:
$11.13
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$994.04M
Einnahmen:
$20.65M
Nettoeinkommen (Verlust:
$-192.65M
KGV:
0.00
EPS:
-2.59
Netto-Cashflow:
$-134.39M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$11.40
Verve Therapeutics Inc Stock (VERV) Company Profile
Firmenname
Verve Therapeutics Inc
Sektor
Branche
Telefon
(978) 501-3026
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie VERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERV
Verve Therapeutics Inc
|
0.00 | 994.04M | 20.65M | -192.65M | -134.39M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.29 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.17 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
841.37 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
395.58 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verve Therapeutics Inc Stock (VERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-12-15 | Eingeleitet | Goldman | Sell |
| 2022-10-06 | Eingeleitet | Credit Suisse | Neutral |
| 2022-08-25 | Hochstufung | Stifel | Hold → Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-09-24 | Eingeleitet | Stifel | Hold |
| 2021-07-12 | Eingeleitet | Guggenheim | Buy |
| 2021-07-12 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-12 | Eingeleitet | Jefferies | Buy |
| 2021-07-12 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Verve Therapeutics Inc Aktie (VERV) Neueste Nachrichten
Is Verve Therapeutics Inc. stock a safe haven asset2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
Will Verve Therapeutics Inc. stock maintain dividend yieldPortfolio Value Report & Real-Time Volume Analysis Alerts - Newser
Will Verve Therapeutics Inc. stock deliver shareholder valueJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Will Verve Therapeutics Inc. stock deliver consistent dividendsEarnings Trend Report & Safe Capital Growth Trade Ideas - Newser
Is Verve Therapeutics Inc. stock positioned for digital transformationDividend Hike & Target Return Focused Picks - BỘ NỘI VỤ
Aug Gainers: Can Verve Therapeutics Inc. stock beat analyst upgradesJuly 2025 Patterns & AI Forecasted Entry and Exit Points - moha.gov.vn
Is Verve Therapeutics Inc. stock a bargain at current levels2025 Momentum Check & Fast Gaining Stock Reports - BỘ NỘI VỤ
Can Verve Therapeutics Inc. stock attract ESG capital inflows2025 Volatility Report & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Verve Therapeutics Inc Stock Analysis and ForecastMoving Average Strategies & Unlock Free Weekly Portfolio Checkups - earlytimes.in
What insider trading reveals about Verve Therapeutics Inc. stockMarket Trend Report & Stock Portfolio Risk Control - newser.com
Price momentum metrics for Verve Therapeutics Inc. explained2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Is Verve Therapeutics Inc. stock in correction or buying zoneRate Hike & Entry Point Strategy Guides - newser.com
How resilient is Verve Therapeutics Inc. stock in market downturnsWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com
What drives Verve Therapeutics Inc stock pricePrice-to-Earnings Ratio Insights & Rapid Profit Portfolio - earlytimes.in
Automated trading signals detected on Verve Therapeutics Inc.July 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Can Verve Therapeutics Inc. stock withstand economic slowdownWeekly Investment Report & Fast Moving Trade Plans - newser.com
Verve Therapeutics Inc. stock daily chart insightsQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Sector ETF performance correlation with Verve Therapeutics Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Is Verve Therapeutics Inc. stock entering bullish territoryWeekly Market Outlook & Daily Price Action Insights - newser.com
Is Verve Therapeutics Inc. stock a safe buy before earningsProduct Launch & Verified High Yield Trade Plans - newser.com
How to track smart money flows in Verve Therapeutics Inc.Earnings Overview Summary & Safe Entry Point Identification - newser.com
Will Verve Therapeutics Inc. stock continue dividend increases2025 EndofYear Setup & Risk Managed Investment Entry Signals - Fundação Cultural do Pará
Technical analysis overview for Verve Therapeutics Inc. stockEarnings Recap Summary & AI Driven Stock Movement Reports - newser.com
Has Verve Therapeutics Inc. formed a bullish divergenceGap Up & Entry Point Strategy Guides - newser.com
Will Verve Therapeutics Inc. bounce back from current supportTrade Signal Summary & Safe Capital Allocation Plans - newser.com
Finanzdaten der Verve Therapeutics Inc-Aktie (VERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):